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Introduction: Type 2 diabetes (T2D) is a complex metabolic disease 
characterized by impaired glucose tolerance. Despite environmental high risk 
factors, host genetic background is a strong component of T2D development. 
Herein, novel highly genetically diverse strains of Collaborative Cross (CC) mice 
were assessed to map quantitative trait loci (QTL) associated with variations of 
glucose tolerance response. 
   
Materials & Methods: Total 501 mice of 58 CC lines were maintained on 
high-fat (42% fat) diet for 12 weeks. Thereafter, an Intraperitoneal Glucose 
Tolerance Test (IPGTT) was performed for 180 minutes. Subsequently Area 
under curve for the glucose values at zero and 180 minutes (AUC0-180), were 
measured, and used for QTL mapping. Heritability and coefficient of variations in 
glucose tolerance (CVg) were calculated.  
 
Results: One-way analysis of variation (ANOVA) was significant (P<0.001) for 
AUC0-180 between the CC lines as well between both sexes. Despite Significant 
variations for both sexes, QTL analysis was significant, only for females, 
reporting a significant females-dependent QTL (~2.5 Mbp) associated with 
IPGTT AUC0-180 trait,   located on Chromosome 8 (32-34.5 Mbp, containing 
51 genes). Gene browse revealed QTL for body weight /size, genes involved in 
immune system and two main protein-coding genes involved in the Glucose 
homeostasis, Mboat4 and Leprotl1. Heritability and coefficient of genetic 
variance (CVg) were 0.49 and 0.31 for Females, while for males 0.34 and 0.22, 
respectively.  
 
Conclusions: Our findings demonstrates the role of genetic factors controlling 
glucose tolerance that significantly differ between sexes requiring independent 
studies for females and males towards T2D prevention and therapy. 
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Introduction 
Type 2 diabetes (T2D) is one of four leading causes of no communicable 
diseases (NCD) deaths in 2012, while according to the World Health 
Organization (WHO) report for 2014; 1.5 million deaths of a total 38 million in 
2012 were caused by diabetes. The annual number of deaths due to non-
communicable diseases  is steadily increasing (unlike infectious diseases) and 
projected to increase from 38 million in 2012 to 52 million by 2030, whereas 
Diabetes is predicted to be 7th cause of death (increase 2-3 places in rank from 
2012 to 2030) (Mathers and Loncar 2002). Etiology of T2D is widely diverse 
involving multiple environmental (lifestyle, physical activity, stress, diet, age 
etc.) and genetic factors and their complex interactions. Type 2 diabetes is one 
of the most ancient known human diseases (Ahmed 2002), characterized by 
complex pathogenesis and despite improvement through the years in T2D 
prevention and therapies via lifestyle and pharmacological intervention (Stevens 
2015), the genetic architecture of the disease is still unexplained. Susceptibility 
towards development and progress of Type 2 diabetes differ between ethnic 
and ancestry (genomic heritage) groups in response to common environmental 
conditions. Individuals from different racial or ethnic groups experience the 
disease differently at the level of co-morbidities, and at the level of Glycemic 
control despite socioeconomic status or health insurance availability (Saydah et 
al. 2007; Harris et al. 1999; Qi at al. 2008). Since the introduction of genome-
wide association studies (GWAS), considerable efforts have been invested in 
exploring genes-environment interactions towards higher risk of T2D. Diet-gene 
interactions were one of the leading studies among populations, several studies 
showed that Westernized dietary patterns had been associated with higher risk 
of impaired glucose tolerance and T2D (Van Dam et al. 2002; Gittelsohn et al. 
1998; Qi and Liang 2010) . To date, GWAS studies revealed approximately 88 
genetic loci associated with T2D and 83 related with glycemic traits (glucose, 
HbA1c, insulin, and proinsulin) (Mohlke and Boehnke 2015). Dissecting the 
genetic architecture of T2D development and progress is crucial for the 
invention of personalized genetic risk prediction tools and discovery of new 
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therapeutic implementations among populations (Bao et al. 2013). Major 
limitation of the human GWAS is lack of proper, controlled, environmental 
factors, which might generate biased results. Therefore, using the mouse model 
in the basal studies of complex diseases is widely accepted, where researchers 
can control the environmental factors while scanning mice from different 
genetic backgrounds. In this context, T2D is considered a complex trait disease, 
where the environmental challenge is the Western diet. The mouse model 
resource used in this study is the new Collaborative Cross (CC), a unique model 
for dissecting QTL of host susceptibility towards the development of T2D in 
response to high-fat (42% Fat) dietary challenge. The CC population was 
created by a community effort of the complex trait consortium (CTC, 
www.complextrait.org) (Churchill et al. 2004; Iraqi et al. 2012; Threadgill and 
Churchill 2012). This unique genetic resource comprises a set of approximately 
300 recombinant inbred lines (RIL) that were created by full reciprocal 8-way 
matings of eight divergent strains of mice: A/J, C57BL/6J, 129S1/SvImJ, 
NOD/LtJ, NZO/HiLtJ, CAST/Ei, PWK/PhJ, and WSB/EiJ. Controlled randomization 
and minimization of selection during the breeding process will recombine the 
natural genetic variation present in these inbred strains. The result is a unique 
collection of RIL exhibiting a large phenotypic and genetic diversity, and brings 
the tremendous genetic variation potential of the mouse inbred lines to 
phenotypic expression (Paterson 1995; Churchill et al. 2004). Full details of CC 
lines and their power of dissecting and mapping QTL associated with host 
susceptibility to complex traits, are presented (Iraqi et al. 2008; Durrant et al. 
2011; Aylor et al. 2011; Philip et al. 2011; Iraqi et al. 2012; Shusterman et al. 
2013; Iraqi et al. 2014; Soller and Iraqi 2014; Vered et al. 2014; Lore et al. 
2015; Levy et al., 2015; Abu Toamih-Atamni et al. 2016a&b; Dorman et al. 
2016). 
 
Herein we demonstrate exclusive use of the CC unique mouse reference 
population to identify QTL and subsequently genes associated with host glucose 
tolerance in response to high fat diet. 
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Materials and Methods 
Ethical statement 
Mice were housed in the small animal facility of the Sackler faculty of medicine 
at Tel-Aviv University (TAU) according to standard protocol approved by the 
animal use and care committee at TAU (approved experiment number M-12-
025).  
Housing and Diet 
Mice were housed, separately by sex and CC line on hardwood chip bedding in 
open-top cages, 12 hours light/dark cycle (6:00 am -6:00 pm)  at 21-230C, 
given tap water and standard rodent chow diet ad libitum (TD.2018SC, Teklad 
Global, Harlan Inc., Madison, WI, USA; containing %Kcal from Fat 18%, Protein 
24%, Carbohydrates 58%), since weaning at age of 3 weeks old, until start of 
the experiment at age of 8 weeks old. To induce the development of 
diabetogenic response, mice were fed by a purified experimental high-fat diet  
(TD 88137 Harlan Teklad, Madison, WI, USA; containing 42% of calories from 
fat and 34.1% from carbohydrate, primarily sucrose) from age of 8 to 20 weeks 
old. 
CC lines 
All the CC lines used in this study are being developed at TAU small animal 
facility. CC lines are developed by full-sib mating technique to exceed currently 
inbreeding generation 16 (G16), further details of the TAU CC colony availablein 
previous reports (Iraqi et al. 2008;  Iraqi et al. 2012). In the current study, we 
used 501 mice generated from 58 CC lines, with representation of both sexes. 
In details, our study cohort consisted of 200 female mice from 44 CC lines and 
301 male mice from 56 CC lines. Sex presentation was not equal for all CC lines 
due to breeding variations between lines.  
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Genotype 
All CC lines were genotyped with high density SNP markers, as previously 
described, and used (Yang et al. 2009; Iraqi et al. 2012; Vered et al. 2014; 
Levy et al. 2015; Abu Toamih-Atamni et al. 2016b). Briefly, all SNPs were 
filtered out with heterozygous or missing genotypes in the 8 CC founders, or 
that were not in common between the arrays. The SNPs were mapped onto 
build 37 of the mouse genome. The HAPPY HMM computed a descent 
probability distribution for each of the used SNPs.  
 
Phenotype  
Diabetogenic effect in response to high-fat dietary challenge was measured by 
the intraperitoneally glucose tolerance test (IPGTT) (Montgomery et al. 2013; 
Leiter et al. 2009) after 12 weeks dietary challenge. For the IPGTT, mice were 
fasted for 6 hours (6:00am-12:00am); with free access to water. Subsequently, 
fasting blood glucose levels were determined at time 0, and then a solution of 
glucose (2.5gr glucose per Kg mouse) was administered by intra-peritoneal (IP) 
injection and blood glucose levels were monitored for 180 minutes (time 0, 15, 
30, 60, 120 and 180 minutes).  Blood glucose levels were measured from tail 
vein using U-RIGHT glucometer TD-4267 (TaiDoc Technology Corporation 3F, 
5F, No.127, Wungong 2nd Rd., 24888 Wugu Township, Taipei County, Taiwan). 
Quantitative glucose clearance ratio of the total 180 minutes IPGTT was 
calculated using area under curve (AUC) trapezoid model from time zero (0) to 
time 180 minutes, as below:  
AUC 
0-180 = 180 minutes * (Glucose level at time 0 + Glucose level at time 180)/2 
Full details of the recorded traits on these mice are presented in Abu Toamih-
Atamni et al. 2016a. 
Statistical Analysis  
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Data analysis was performed using a statistical software package IBM SPSS 
statistics 23. One-Way ANOVA was carried out for testing the significance of 
the AUC0-180 means variations between the different CC lines, a P value of 
0.05 or less was considered significant. 
 
Heritabil ity and coefficient of genetic variation 
Heritability (H2) is a statistic that estimates the fraction of phenotypic variance 
that can be attributed to genetic variance among the population. Here, we used 
the ANOVA results of the AUC0-180 trait to calculate the broad sense 
heritability (including epistatic, but not dominance effects) using the H2 formula 
below: 
H2= Vg/(Vg+Ve) 
Where, H2 is the heritability, Vg is the genetic variance among CC lines ((MSbetween 
– Ve)/n) and Ve is the environment variance (MSwithin= variance within CC line).  
Following heritability statistic, we calculated the genetic coefficient of variation 
(CVG), which indicate the absolute amount of genetic variation (between CC 
lines). CVG was calculated using the result of standard deviation among CC lines 
(SDG) and trait mean (AUC0-180) overall CC lines, as below: 
CVG = SDG/Mean 
For further details on calculations, see Iraqi et al. 2014. 
 
QTL mapping 
The HAPPY package also tests for the existence of a QTL at each locus using 
the estimated probabilities of descent from the founder strains to estimate the 
phenotypic effect attributable to each founder strain. If these effects are 
significantly different then there is evidence for a QTL. Thus, for the initial stage 
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of linkage analysis based on single trait analysis, a standard polyallelic "marker" 
model will be used. This model tests whether there is an overall association 
between the marker and the trait by comparing after fitting the complete model 
including the mean, any fixed effects such as sex and generation, and the 
marker alleles  
 
Merge analysis 
Testing sequence variations segregation between the CC founders, using merge 
analysis to fine-tune the AUC0-180 QTL and identify candidate genes. Analysis 
methodology will be merged (Yalcin et al. 2005) to test which variants under a 
QTL peak were compatible with the pattern of action at the QTL. We used the 
Perlegen SNP database to test sequence variants globally and the Sanger SNP 
database for individual genes. A successful use of this approach was recently 
published (Durrant et al. 2011; Vered et al. 2014; Levy et al. 2015; Abu-
Toamih Atamni et al. 2016b).  
 
Genome Browser 
Using the Mouse Genome Informatics (MGI) database resource 
(http://www.informatics.jax.org/), enabled us to examine the reported QTL in 
details for genetic features located within the QTL genomic interval, related to 
glucose homeostasis/metabolism or involved systems in type 2 diabetes, such 
as immune/endocrine systems. The MGI search revealed known-genes, mRNAs, 
QTLs and more. Each result suggested at the MGI was further investigated in 
the literature for biological roles.  
 
Results  
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Following 12 weeks of High-Fat dietary (HFD) challenge, the CC lines 
diabetogenic response was assessed by an Intraperitoneal Glucose Tolerance 
Test (IPGTT) for 180 minutes. Thereafter, the overall area under curve (AUC0-
180) of the glucose clearance was calculated and used as an indicator for 
diabetic status, where higher levels of AUC0-180 were associated with slower 
glucose clearance and even impaired glucose tolerance. Genotypic data of the 
CC lines was scanned using the HAPPY software for genetic linkage with the 
trait AUC0-180, first for overall population and then for females and males 
separately. All results reported in details below, starting from phenotypic data, 
heritability and CVg calculations, to QTL analysis and founders’ effect analysis, 
ending with Identification of candidate genes.     
 
Glucose tolerance significant variations between CC lines 
As shown in Fig.1 (A, B and C), One-way analysis of variation (ANOVA) revealed 
highly significant variations for AUC0-180 means between CC lines overall 
population (Fig.1A) (F (57,443) = 4.93, p<0.001), also for females (Fig.1B) (F 
(43,156) = 4.38, p<0.001) and males (Fig.1C) (F (55,245) = 3.23, p<0.001), 
separately. The overall CC lines population (n=501 / 58 CC lines) showed mean 
AUC0-180 of 45515.6 (±846.8) mg/dL*min, while mean values ranged 
between IL-2146 representing the lowest value of 24345 (±6345) mg/dL*min 
and IL-2452 representing the highest value of 82575, and IL-2457 located at 
median point of 45495 (±8685) mg/dL*min. 
 
Females AUC0-180 significantly lower than Males 
From the total assessed 58 CC lines, 42 lines had representation of both sexes 
(Females - n=194 / Males – n=245). Two-way ANOVA was used to assess the 
significance of sex and line interaction (combined effects) affecting AUC0-180 
means variations. ANOVA output revealed a highly significant independent sex 
10 
 
and line effects (p<0.001), and significant Sex * Line interactions (p<0.05) 
influencing AUC0-180 variation of means. The reported AUC0-180 means were 
35847.1 (±1285.6) mg/dL*min for females versus 48690.1 (±1209.1) 
mg/dL*min for males,  ~1.4 folds difference in favor of females at 83% (35 of 
42 CC lines) of the cases and favor of males only at 16% (7 of 42 CC lines) of 
the cases (lower AUC0-180 indicates effective glucose clearance). The difference 
of AUC0-180 means between sexes within each individual CC line, varied in a 
wide range among the CC population as shown in Fig.2.  
 
Heritabil ity and Genetic coefficient variation 
Heritability estimates have a value between 0 to 1. As shown in table 1, 
heritability (H2) and genetic coefficient variation (CVG) calculations revealed 
values of 0.34 and 0.25, respectively, for the overall CC lines population. When 
data was split by sex, H2 and CVG values were, respectively, 0.49 and 0.31 for 
females, while 0.34 and 0.22 for males. H2 value of 0.5 and above can be 
considered as high heritability of the trait hence the reported AUC0-180 H2 
value of the females (0.49) is high, indicating that 49% of the observed 
variation of AUC0-180 between the CC lines is due to genetic factors. 
Consequently, CVG value of the females reveals that 31% of the genetic 
variations among CC lines were generated by these genetic factors.  
 
Females-dependent QTL associated with AUC0-180 trait and founder 
effect 
Initially, we performed QTL mapping for AUC0-180 trait for the entire 
population of the 501 mice of the 58 CC lines, including males and females. 
However, no significant QTL were detected. Subsequently, we performed QTL 
mapping for male and females, separately. Interestingly, data analysis for male 
only, did not show any significant QTL. However, the female data, indeed 
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showed significant QTL located on Chr8 with genomic interval of 2.5 Mbp 
(32.02-34.52 Mbp) (logP=5.9) as presented in Fig.3. The threshold based on 
permutation test is presented in figure and found to be -logP =5.65. 
 
 
Founder effect 
We evaluated the effect of each founder genotype at the females AUC0-180 
mapped QTL interval, and estimated to the assessed trait. Results of this 
analysis are presented for the QTL in Fig.4. The locus showed complex pattern 
of haplotype effects of the founders, with the wild-derived strains (mainly PWK) 
playing a major role on increase AUC values, while NZO genotype reduce this 
trait, although other strains also contributed (positive or negative) to the 
overall QTL effect. 
 
Merge analysis 
Testing sequence variations segregation between the CC founders, using merge 
analysis to fine-tune the AUC0-180 QTL and identify candidate genes. Fig.5 
shows the merge analysis, and interestingly our results have shown that the 
majority of the SNPs within the haplotype QTL interval are highly significant and 
enabled higher resolution of the QTL peak location (logP score=5.9, threshold 
5.65 at P-value<0.05).   
 
Identification of candidate genes within the mapped QTL interval  
The reported QTL contains 13 protein-coding genes, 10 QTLs and other genetic 
features (non-coding RNA/ heritable phenotypic markers/gene segments/ 
pseudogenes). The protein coding genes with most relevance to glucose 
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tolerance were related to immune system, endocrine system and regulation of 
glucose homeostasis.  
With most relevance to the glucose homeostasis traits, we may suggest genes 
involved in regulation glucose homeostasis, such as Mboat4 (MGI:2685017), 
named membrane bound O-acyltransferase domain containing 4, which encodes 
enzymes that transfer organic acids, typically fatty acids, onto hydroxyl groups 
of membrane-embedded targets (Hofmann 2000). MBOAT4 mediates the 
octanoylation of the stomach hormone ghrelin (GOAT - Ghrelin O-
Acyltransferase), which plays endocrine role in the regulation of glucose 
homeostasis (Yang et al. 2008; Kirchner et al. 2013). 
Another major candidate gene is Leprotl1 (MGI:1915442), named leptin 
receptor overlapping transcript-like 1, plays a role in the control of hepatic 
Growth Hormone (GH) resistance to involved between nutritional signals and GH 
actions on body growth and metabolism. LEPROTL1 expression is regulated in 
the mouse liver by physiologic and pathologic changes in glucose homeostasis 
(Touvier et al. 2009). As well, we observed the Wrn gene (MGI:109635), named 
Werner syndrome homolog (human) and involved in age-related osteoporosis, 
adipose tissues/ cardiovascular system/ digestive/ growth/ size/ body/ 
immune system/ mortality/ aging (Tracy et al. 2014). 
Furthermore, the MGI search revealed candidate genes involved in the immune 
system, and might be indirectly related to the Type 2 diabetes progress as an 
inflammatory disease. One of the observed genes was the Gsr gene, named 
glutathione reductase (MGI:95804), and had been shown to be involved in 
immune response against bacterial challenge (phagocytes), catalyzes the 
reduction of glutathione disulfide to glutathione (Yan et al. 2012), alongside 
additional functionaries in Cardiovascular System / vision eye (Blackshaw et al. 
2004), also crucial for limiting tissue damage (Rogers et al. 2006) which are 
highly engaged to T2D metabolic syndrome health complication.  
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Saraf gene (MGI:1915137), named store-operated calcium entry-associated 
regulatory factor, involved inter alia in the Endocrine system , rather in the 
Pancreas development (Hoffman et al. 2008), the major organ of the body that 
respond to glucose levels and plays main role in glucose homeostasis.  
In addition to protein coding genes, ten QTL feature types were exposed, 
located within our QTL genomic interval; eight of the ten QTLs were with 
relevance to our phenotype and therefore mentioned here. Three named Egq12 
(early growth QTL 12), W10q14 (weight 10 weeks QTL 14) and W6q9 (weight 
6 weeks QTL 9) were related to Growth and body size (Rocha et al. 2004). 
Another three QTLs named Eae36 (experimental allergic encephalomyelitis 
susceptibility 36) (MazónPeláez et al. 2005), Hbnr12 (Heligmosomoides bakeri 
nematode resistance 12) (Behnke et al. 2010) and Pgia4 (proteoglycan induced 
arthritis 4) (Otto et al. 1999), related to different immune system responses. 
Following the previously mentioned order of the immune system QTLs, the first 
related Inflammatory demyelinating disease of the nervous system (EAE), the 
second related to Immune response to infection (Heligmosomoides bakeri), and 
the third associated with autoantibody production in the context of rheumatoid 
arthritis (RA) study in the murine model Proteoglycan-induced arthritis (PGIA). 
Two additional QTLs were related to known T2D high risk co-morbidities, one 
associated with bone mineral density, Bmd39 (sex-specific), named bone 
mineral density 39, and linked to bone geometry and strength (Robling et al. 
2007). Previous studies reported osteopenia and osteoporosis complications of 
T2D diabetes (Mathen et al. 2015), even though several studies shows that 
BMD levels were not affected by T2D (Caglayan et al. 2015), the incidence of 
bone fracture is increased among T2D patients, suggesting that quality of the 
bones might still be affected by the disease (Carnevale 2014). The second 
comorbidity was associated with tumor genesis of colon cancer, Scc8, named 
colon tumor susceptibility 8 (van Wezel et al. 1999). According to studies and 
most recent meta-analysis diabetic patients have an increased risk of colon 
cancer compared to non-diabetic (Guraya 2015). 
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Finally, Human - Mouse: Disease Connection (HMDC) search for the given QTL 
genomic location revealed about 18 gene homologs from 28 
phenotypes/diseases. Out of this list, directly relevant to glucose tolerance 
trait, six genes (GSR/Leprotl1/Mboat4/Nrg1/Tex15 and WRN) _ with homologs 
in human are suggested playing important role in the homeostasis/metabolism 
system.     
 
Discussion 
Herein, we demonstrate, for the first time, the implementation of the unique 
Collaborative Cross (CC) mouse model to study the complex genetic 
architecture of type 2 diabetes in response environmental dietary challenge of 
high-fat diet (42%). The accumulated data of T2D studies proves repeatedly 
the complexity of the disease etiology, once attributed mainly to environmental 
risk factors, and today is known to be controlled by numerous genetics-
environment interactions. Therefore, massive efforts are invested for dissecting 
the genetic architecture of T2D, which will restrain the alarming predictions for 
T2D epidemic, first at the level of quick diagnosis using genetic biomarker and 
second at the level of personalized medicine. Achieving this challenge requires 
great efforts, collaboration of scientists and clinicians and the realization that 
T2D differ among populations and should be defined into categories based on 
genetic and environmental factors.  
Human GWAS survey revealed, so far, at least 88 genetic loci associated with 
T2D and 83 related with glycemic traits (Mohlke and Boehnke 2015), require 
further study to understand their biological role and mechanism involved in T2D.  
Interestingly, none of the genes, which were mapped within our QTL interval, 
identified in the human mapped genes. Therefore, we considered our results to 
be novel by identifying new genes associated with the tested trait. Human 
GWAS methodologies ameliorate in recent years with evident success to unravel 
phenotype-genotype associations, nevertheless, this powerful tool arises several 
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limitations mainly due to lack of proper control and constraints of further trials 
in human population under controlled environments for investigation of 
candidate genes biological roles/functioning. Hence, using an animal model for 
human diseases study was dedicated to overcome these limitations. Particularly 
for GWAS studies, the mouse model is widely used with notable potential due to 
many advantages, including availability of mouse genomic data resources, 
availability of genetic experimental tools, ease of breeding and ability of strictly 
controlled environmental conditions (Cox and Church 2011). For this purpose, 
the Collaborative Cross (CC) mouse population was designated, representing a 
model for heterogeneous human population for dissecting phenotypic-genotypic 
association underling differences among population towards common 
environmental exposure. In the present study, the CC lines corresponds for 
heterogeneous population and high-fat diet (HFD - 42% fat) corresponds for 
T2D risk environmental challenge, whereas QTL mapping analyzes the linkage 
between diabetogenic phenotype (impaired glucose tolerance measured as 
AUC0-180) and genotypic components. Once a QTL mapped, the next level will 
be search for candidate genes, validation of candidate gene and functioning 
pathways, towards translation to advanced level of human genetics, a numerous 
efforts invested by extensive collaborations of basic and clinical researchers. 
In the current study, QTL mapping revealed a new sex-specific loci standing for 
total Area Under Curve in response to HFD, calculated for the area under curve 
between start time point to end time point of the 180 minutes Intraperitoneal 
Glucose Tolerance Test (IPGTT). Eventually, data processing exposed various 
patterns of glucose clearance process that differ significantly between the CC 
lines in response to the same environmental conditions. Additionally, a 
significant sex effect was observed for the overall CC lines population, in which 
AUC0-180 of Males was higher than Females, indicating greater glucose 
clearance impairment in response to HFD for males, i.e. higher sensitivity to HFD 
induced glucose-impaired tolerance than in females. Sex difference was 
significant as an overall trend but varied between the CC lines, when examined 
within each CC line.     
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The reported QTL, is a females-dependent, named AUC0-180 QTL (~2.5 Mb) 
and mapped at genomic location of Chr8:32.02-34.52 Mb. Merge analysis 
enabled higher resolution of the QTL peak location (logP = 5.9, threshold P-
value<0.05), thereafter we scanned the observed interval for candidate genes 
using the international database resource for the laboratory mouse, Mouse 
Genome Informatics (MGI; http://www.informatics.jax.org). The scanned interval 
included 10 QTL and 50 genes, of which 13 genes were protein-coding genes, 
studied with known functions. Amongst the 13 protein coding genes, Mboat4 
(MGI: 2685017) and Leprotl1 (MGI: 1915442) reported to be highly involved in 
regulation of glucose homeostasis, an evidence to support the significance of 
the AUC0-180 association with glucose tolerance phenotype. As well, 8 out of 
the mentioned 10 QTL were related to phenotypes of high relevance to 
impaired glucose tolerance and T2D co-morbidities, such as body weight and 
size, immune response, bone mineral density and colon cancer. Recently, we have 
published results of mapping QTL for females, only with non-alcoholic fat liver accumulations 
(Abu Toamih-Atamni et al. 2016b). It is believed that there are different mechanisms that 
control obesity and related diseases including NAFLD and blood glucose in males and females. 
Furthermore, we searched the AUC0-180 interval for Human–Mouse Disease 
Connection (HMDC; http://www.informatics.jax.org/humanDisease.shtml) to 
identify possible connections of our findings in the mouse genome to 
corresponding genetic findings reported in the human disease. Search results 
revealed 5 gene homologs in humans (Wrn/ Tex15/Ppp2cb/Gsr/Mboat), where 
the genes Wrn and Mboat associated with phenotypes of growth/size/body and 
homeostasis/metabolism pathways. Two of the 5 mentioned homologous genes, 
Wrn and Gsr, were associated with known human diseases, Werner Syndrome 
and Glutathione Reductase disease, respectively.  Werner Syndrome, attributed 
to Wrn protein coding gene, is characterized by wide range of metabolic/growth 
complications, including development of T2D. Glutathione Reductase disease, 
attributed to Gsr protein coding gene deficiency leading to multiple 
complications including Cardiovascular system and cataract development, which 
are known as main complication also in T2D. Altogether, genes search of AUC0-
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180 interval corroborates the significance of our findings to be relevant to T2D 
direct/indirect pathways, along with the suitability of using AUC0-180 as 
diabetogenic phenotype. 
Finally, in previous studies researchers, usually focus on impaired glucose 
clearance, but less on QTL associated with improved glucose clearance. This 
report is one of the few studies that addresses both, impaired glucose clearance 
phenomenon and QTL associated with this trait.     
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Figures Legend:  
Fig. 1: Total area under curve  (AUC0-180) of glucose clearance (min*mg/dL) 
at initial (time 0) and 180 minutes of intraperitoneal glucose tolerance test 
(IPGTT) of different CC lines in response to HF (42% Fat) dietary challenge. Bar 
graph (A) shows IPGTT total AUC of 58 CC lines of overall CC lines population. 
Bar graph (B) shows IPGTT total AUC of females from 44 CC lines. Bar graph (C) 
shows total AUC of males  from 56 CC lines. X-axis line number, representsthe 
different CC lines. Y-axis represents the total area under curve of glucose 
clearance (min*mg/dL) at initial (time 0) and 180 minutes of intraperitoneal 
glucose tolerance test (IPGTT) . Significant variation was found between the 
different CC lines at P<0.001. 
Fig.2: Difference between sexes of AUC0-180 (mg/dL*min) means within each 
CC line (Total 42 CC lines) in response to HF (42% Fat) ditary challenge. The 
difference calcualted between means of AUC0-180 of males and females from 
the same CC line (Δ AUC0-180= Males – Females). X-axis represents the 
different CC lines. Y-axis represents the total area under curve of glucose 
clearance (min*mg/dL) at initial (time 0) and 180 minutes of intraperitoneal 
glucose tolerance test (IPGTT).  
Fig. 3: Genome scan of Quantitative Trait Loci (QTL) associated with total area 
under curve of glucose clearance (AUC0-180 (mg/dL*min))  trait in female mice, 
in a population of 44 Collaborative Cross (CC) lines after 12 weeks on high-fat 
(42% Fat) dietary challenge. X-axis represents the  19 mouse Chromosomes 
and the position of mapped QTL on Chromosome 8 (Chr8). Y-axis represents the 
logP of the test of association between locus and AUC0-180 trait. QTL with logP 
exceeded 5.65 threshold, based on permutaion genome wide test, at significant 
level of P<0.05 was identified. 
Fig. 4: Estimated effect size on total area under curve of glucose clearance 
(AUC0-180) (mg/dL*min)) for the 8 CC founder strains for Chromosome 8 QTL.  
X-axis represents eight founder strains of the CC mice. Y-axis represents 
haplotype effect size of the CC founder at the AUC0-180 QTL. 
Fig. 5: Merge analysis of sequence variants around the AUC0-180 QTL on 
Chromosome 8 in the Collaborative Cross (CC) lines. X-axis represents the genomic 
location. Y-axis represents the logP of the linkage analysis between AUC0-180 
and the locus. The orange dots  resemble the results of merge analysis. The 
blue continues line resemble the haplotype QTL mapping scan on Chromosome 
8.  
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Table 1: Position of the QTL underlying the total area under curve of glucose 
clearance trait (AUC0-180 QTL) associated with impaired glucose tolerance in 
response to 12 weeks HF  (42% Fat) dietary challenge in Collaborative Cross 
(CC)  lines. QTL; Quantitative Trait Loci, Chr; Chromosome, -logP- negative 
logarithm of significance value, H2, estimated broad-sense heritability, CVg; 
coefficient of genetic variation.  
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Figure 1. Phenotypic profile of AUC0-180 of total CC population (A), male, only (B) and 
female, only (C). 
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Figure 2: Differences of AUC0-180 between males and females CC mice 
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Figure 3. Mapped QTL with AUC0-180 trait 
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Figure 4. Founder Effect 
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Fig. 5: Merge analysis 
 
 
 
 
 
 
 
 
